Compare BLLN & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | DAN |
|---|---|---|
| Founded | 2016 | 1904 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.3B |
| IPO Year | N/A | 1998 |
| Metric | BLLN | DAN |
|---|---|---|
| Price | $73.45 | $36.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $126.71 | $40.60 |
| AVG Volume (30 Days) | 380.2K | ★ 805.1K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | N/A | ★ 264.10 |
| EPS | N/A | ★ 0.64 |
| Revenue | N/A | ★ $7,500,000,000.00 |
| Revenue This Year | $46.29 | $1.89 |
| Revenue Next Year | $30.14 | $4.59 |
| P/E Ratio | ★ N/A | $58.66 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $61.96 | $13.45 |
| 52 Week High | $138.70 | $39.56 |
| Indicator | BLLN | DAN |
|---|---|---|
| Relative Strength Index (RSI) | 41.26 | 51.15 |
| Support Level | $64.99 | $34.66 |
| Resistance Level | $83.20 | $36.28 |
| Average True Range (ATR) | 6.48 | 1.21 |
| MACD | -1.05 | -0.06 |
| Stochastic Oscillator | 9.57 | 28.67 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.